000 01073 a2200289 4500
005 20250516154534.0
264 0 _c20140127
008 201401s 0 0 ger d
022 _a1439-3522
024 7 _a10.1055/s-0033-1335247
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpeck, V
245 0 0 _a[Migraine - established concepts and new developments].
_h[electronic resource]
260 _bFortschritte der Neurologie-Psychiatrie
_cJun 2013
300 _a308-23 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aBotulinum Toxins, Type A
650 0 4 _aHumans
650 0 4 _aMigraine Disorders
_xclassification
650 0 4 _aPrevalence
650 0 4 _aTryptamines
_xtherapeutic use
700 1 _aMaihöfner, C
773 0 _tFortschritte der Neurologie-Psychiatrie
_gvol. 81
_gno. 6
_gp. 308-23
856 4 0 _uhttps://doi.org/10.1055/s-0033-1335247
_zAvailable from publisher's website
999 _c22844164
_d22844164